2022年恐慌市场----规模、增长、趋势 到2030年时

Table of Content

1.Introduction

1.1.Market Introduction
1.2.Market Research Methodology
1.2.1.Research Process
1.2.2.Primary Research
1.2.3.Secondary Research
1.2.4.Data Collection Technique
1.2.5.Data Sources
1.3.Market Estimation Methodology
1.3.1.Limitations of the Study
1.4.Product Picture of Panic Disorder
1.5.Global Panic Disorder Market: Classification
1.6.Geographic Scope
1.7.Years Considered for the Study
1.8.Research Methodology in Brief
1.9.Parent Market Overview
1.10. Panic Disorder Market Regional Demand
1.11. Research Programs/Design
1.12. Market Breakdown and Data Triangulation Approach
1.13. Data Source
1.14. Secondary Sources
1.15. Primary Sources
1.16. Primary Interviews
1.17. Average Primary Breakdown Ratio

2.Market Dynamics

2.1.Drivers
2.1.1.Drivers
2.2.Restraints
2.2.1.Restraints
2.3.Opportunity
2.3.1.Impact Forces on Market Dynamics
2.3.2.Impact Forces During the Forecast Years
2.4.Industry Value Chain
2.4.1.Upstream Analysis
2.4.2.Downstream Analysis
2.4.3.Distribution Channel
2.4.4.Direct Channel
2.4.5.Indirect Channel
2.5.Potential Customers
2.6.Manufacturing/Operational Cost Analysis
2.7.Pricing Analysis by Region
2.8.Key Technology Landscape
2.9.Porter\'s Analysis
2.9.1.Supplier Power
2.9.2.Buyer Power
2.9.3.Substitution Threat
2.9.4.Threat from New Entry
2.9.5.Competitive Rivalry
2.10. PESTEL Analysis
2.10.1. Political Factors
2.10.2. Economic Factors
2.10.3. Social Factors
2.10.4. Technological Factors
2.10.5. Environmental Factors
2.10.6. Legal Factors

3.Global Panic Disorder Market Segmentation, by Revenue (USD Million), (2023-2030)

3.1.By Treatment Type
3.1.1.Psychotherapy
3.1.2.Medication
3.1.2.1.Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
3.1.2.2.Benzodiazepines
3.1.2.3.Others
3.1.3.Others
3.2.By Dosage Form
3.2.1.Tablets
3.2.2.Injections
3.2.3.Others
3.3.By End User
3.3.1.Hospitals and Clinics
3.3.2.Mental Healthcare Centres
3.3.3.Others

4.Global Panic Disorder Market Overview, By Region

4.1. North America Panic Disorder Market Revenue (USD Million), by Countries, (2023-2030)
4.1.1. U.S.
4.1.1.1.By Treatment Type
4.1.1.2.By Dosage Form
4.1.1.3.By End User
4.1.2.Canada
4.1.3.Mexico
4.2.Europe Panic Disorder Market Revenue (USD Million), by Countries, (2023-2030)
4.2.1.Germany
4.2.2.France
4.2.3.UK
4.2.4.Spain
4.2.5.Russia
4.2.6.Italy
4.2.7.BENELUX
4.3.Asia Pacific Panic Disorder Market Revenue (USD Million), by Countries, (2023-2030)
4.3.1. China
4.3.2. Japan
4.3.3. Australia
4.3.4. South Korea
4.3.5. India
4.3.6. ASEAN
4.4.Latin America Panic Disorder Market Revenue (USD Million), by Countries, (2023-2030)
4.4.1. Brazil
4.4.2. Argentina
4.4.3. Chile
4.5.Middle East and Africa Panic Disorder Market Revenue (USD Million), by Countries, (2023-2030)
4.5.1.GCC
4.5.2.Turkey
4.5.3.South Africa

5.Global Panic Disorder Market Revenue: Competitive Analysis, 2022

5.1.Key Strategies by Players
5.2.Revenue (USD Million) and Market Share (%), By Manufacturers, 2022
5.3.Player Positioning by Market Players, 2022

6.Competitive Analysis

6.1.Pfizer Inc.
6.1.1.Business Overview
6.1.2.Business Financials (USD Million)
6.1.3.Product Category, Type, and Specification
6.1.4.Main Business/Business Overview
6.1.5.Geographical Analysis
6.1.6.Recent Development
6.1.7.SWOT Analysis
6.2.Sun Pharmaceutical Industries Ltd.
6.3.F. Hoffmann-La Roche AG
6.4.Eli Lilly & Company
6.5.Sumitomo Dainippon Pharma Co.
6.6.GSK Group of Companies
6.7.Recordati Rare Diseases, Ltd.
6.8.Bausch Health Companies Inc.
6.9.LIFECARE NEURO PRODUCTS LTD.
6.10.Neuraxpharm

7.Market Research Findings & Conclusion

Disclaimer